Company intelligence / Profile preview

DIESSE Diagnostica Senese

Siena / Monteriggioni, Tuscany, Italydiesse.it ↗

Ownership: Private
Employees: ~185
Development stage: Commercial

Overview

DIESSE Diagnostica Senese has a long-standing track record in developing and commercializing innovative in vitro diagnostic systems. Its products are used globally for immunodiagnostics and automated ESR measurement. The company developed one of the first blood tests capable of tracking COVID‑19 antibodies and has received EU IVDR certification for its quality management system covering Class A, B, and C devices[1][8][10].

Therapeutic areas: HematologyImmunologyInfectious Diseases
Modalities: DeviceDiagnostic reagentImmunochemistry assay
Industry: Protein Biomarker Diagnostics

Partnerships

Lazzaro Spallanzani National Institute for Infectious Diseases (COVID‑19 test validation)

Beyond the preview

Go deeper on DIESSE Diagnostica Senese.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DIESSE Diagnostica Senese.

Explore the full profile